These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26169471)

  • 1. Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis.
    Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
    Metabolism; 2015 Oct; 64(10):1324-33. PubMed ID: 26169471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis.
    Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
    Cancer Epidemiol; 2015 Dec; 39(6):1026-35. PubMed ID: 26388613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.
    Limburg PJ; Stolzenberg-Solomon RZ; Vierkant RA; Roberts K; Sellers TA; Taylor PR; Virtamo J; Cerhan JR; Albanes D
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1514-21. PubMed ID: 17162243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly?
    Foltyn W; Kos-Kudla B; Strzelczyk J; Matyja V; Karpe J; Rudnik A; Marek B; Kajdaniuk D; Sieron A; Latos W
    Neuro Endocrinol Lett; 2008 Feb; 29(1):107-12. PubMed ID: 18283256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studies.
    Keum N; Lee DH; Kim R; Greenwood DC; Giovannucci EL
    Ann Oncol; 2015 Jun; 26(6):1101-1109. PubMed ID: 25480876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between markers of glucose metabolism and risk of colorectal cancer.
    Xu J; Ye Y; Wu H; Duerksen-Hughes P; Zhang H; Li P; Huang J; Yang J; Wu Y; Xia D
    BMJ Open; 2016 Jun; 6(6):e011430. PubMed ID: 27354075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies.
    Godos J; Biondi A; Galvano F; Basile F; Sciacca S; Giovannucci EL; Grosso G
    World J Gastroenterol; 2017 Mar; 23(10):1909-1919. PubMed ID: 28348498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal obesity and the risk of colorectal adenoma: a meta-analysis of observational studies.
    Hong S; Cai Q; Chen D; Zhu W; Huang W; Li Z
    Eur J Cancer Prev; 2012 Nov; 21(6):523-31. PubMed ID: 22343656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
    Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
    Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance, apoptosis, and colorectal adenoma risk.
    Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance, central obesity, and risk of colorectal adenomas.
    Ortiz AP; Thompson CL; Chak A; Berger NA; Li L
    Cancer; 2012 Apr; 118(7):1774-81. PubMed ID: 22009143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron intake, serum iron indices and risk of colorectal adenomas: a meta-analysis of observational studies.
    Cao H; Wang C; Chai R; Dong Q; Tu S
    Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26956572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Secretion of Glucagon-Like Peptide 1 in Patients with Colorectal Adenoma after an Oral Glucose Load.
    Sasaki Y; Abe Y; Takeda H; Nishise S; Yaoita T; Yagi M; Sakuta K; Mizumoto N; Shoji M; Onozato Y; Kawata S; Ueno Y
    Digestion; 2018; 97(4):324-332. PubMed ID: 29539609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index increases risk for colorectal adenomas based on meta-analysis.
    Ben Q; An W; Jiang Y; Zhan X; Du Y; Cai QC; Gao J; Li Z
    Gastroenterology; 2012 Apr; 142(4):762-72. PubMed ID: 22245665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between investigator-measured body-mass index and colorectal adenoma: a systematic review and meta-analysis of 168,201 subjects.
    Wong MC; Chan CH; Cheung W; Fung DH; Liang M; Huang JL; Wang YH; Jiang JY; Yu CP; Wang HH; Wu JC; Chan FK; Sung JJ
    Eur J Epidemiol; 2018 Jan; 33(1):15-26. PubMed ID: 29288474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
    Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
    Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between markers of glucose metabolism and risk of colorectal adenoma.
    Rampal S; Yang MH; Sung J; Son HJ; Choi YH; Lee JH; Kim YH; Chang DK; Rhee PL; Rhee JC; Guallar E; Cho J
    Gastroenterology; 2014 Jul; 147(1):78-87.e3. PubMed ID: 24632359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies.
    Yu F; Guo Y; Wang H; Feng J; Jin Z; Chen Q; Liu Y; He J
    BMC Cancer; 2016 Aug; 16():642. PubMed ID: 27535548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral adipose tissue and the risk of colorectal adenomas: a meta-analysis of observational studies.
    Hu H; Cai Y; Huang J; Zhang J; Deng Y
    Eur J Cancer Prev; 2015 Nov; 24(6):462-9. PubMed ID: 25494291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.